90Y-DOTATATE

N/A

Report date: 2025/11/20 11:38:22

NME

Base Information

Drug Name90Y-DOTATATE

Drug Alias Name钇[90Y]-氧奥曲肽90Y-DOTATATE

ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor 2 modulators

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Warmia And Mazury In Olsztyn

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Warmia And Mazury In Olsztyn

Active IndicationsN/A

Inactive IndicationsNeuroendocrine Tumors

Other Information

ATC CodeN/A